Muthuswamy S K, Gilman M, Brugge J S
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Mol Cell Biol. 1999 Oct;19(10):6845-57. doi: 10.1128/MCB.19.10.6845.
The four members of the ErbB family of receptor tyrosine kinases are involved in a complex array of combinatorial interactions involving homo- and heterodimers. Since most cell types express more than one member of the ErbB family, it is difficult to distinguish the biological activities of different homo- and heterodimers. Here we describe a method for inducing homo- or heterodimerization of ErbB receptors by using synthetic ligands without interference from the endogenous receptors. ErbB receptor chimeras containing synthetic ligand binding domains (FK506-binding protein [FKBP] or FKBP-rapamycin-binding domain [FRB]) were homodimerized with the bivalent FKBP ligand AP1510 and heterodimerized with the bifunctional FKBP-FRB ligand rapamycin. AP1510 treatment induced tyrosine phosphorylation of ErbB1 and ErbB2 homodimers and recruitment of Src homology 2 domain-containing proteins (Shc and Grb2). In addition, ErbB1 and ErbB2 homodimers activated downstream signaling pathways leading to Erk2 and Akt phosphorylation. However, only ErbB1 homodimers were internalized upon AP1510 stimulation, and only ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to form foci; however, cells expressing ErbB2 homodimers displayed a five- to sevenfold higher focus-forming ability. Using rapamycin-inducible heterodimerization we show that c-Cbl is unable to associate with ErbB1 in a ErbB1-ErbB2 heterodimer most likely because ErbB2 is unable to phosphorylate the c-Cbl binding site on ErbB1. Thus, we demonstrate that ErbB1 and ErbB2 homodimers differ in their abilities to transform fibroblasts and provide evidence for differential signaling by ErbB homodimers and heterodimers. These observations also validate the use of synthetic ligands to study the signaling and biological specificity of selected ErbB dimers in any cell type.
受体酪氨酸激酶ErbB家族的四个成员参与了一系列复杂的组合相互作用,包括同二聚体和异二聚体。由于大多数细胞类型表达不止一种ErbB家族成员,因此很难区分不同同二聚体和异二聚体的生物学活性。在此,我们描述了一种通过使用合成配体诱导ErbB受体同二聚化或异二聚化的方法,且不会受到内源性受体的干扰。含有合成配体结合结构域(FK506结合蛋白[FKBP]或FKBP-雷帕霉素结合结构域[FRB])的ErbB受体嵌合体与二价FKBP配体AP1510发生同二聚化,并与双功能FKBP-FRB配体雷帕霉素发生异二聚化。AP1510处理诱导了ErbB1和ErbB2同二聚体的酪氨酸磷酸化以及含Src同源2结构域蛋白(Shc和Grb2)的募集。此外,ErbB1和ErbB2同二聚体激活了下游信号通路,导致Erk2和Akt磷酸化。然而,只有ErbB1同二聚体在AP1510刺激下发生内化,并且只有ErbB1同二聚体能够与c-Cbl结合并诱导其磷酸化。表达AP1510诱导的ErbB1同二聚体的细胞能够与c-Cbl结合并诱导其磷酸化。表达AP1510诱导的ErbB1同二聚体的细胞能够形成集落;然而,表达ErbB2同二聚体的细胞显示出高五到七倍的集落形成能力。使用雷帕霉素诱导的异二聚化,我们发现c-Cbl在ErbB1-ErbB2异二聚体中无法与ErbB1结合,这很可能是因为ErbB2无法磷酸化ErbB1上的c-Cbl结合位点。因此,我们证明了ErbB1和ErbB2同二聚体在转化成纤维细胞的能力上存在差异,并为ErbB同二聚体和异二聚体的差异信号传导提供了证据。这些观察结果也验证了使用合成配体来研究任何细胞类型中选定的ErbB二聚体的信号传导和生物学特异性。